Wealth Alliance LLC acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,741 shares of the company’s stock, valued at approximately $203,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. N.E.W. Advisory Services LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter worth about $25,000. Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies during the second quarter worth about $34,000. Game Plan Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after buying an additional 375 shares during the period. Zions Bancorporation National Association UT acquired a new stake in shares of GE HealthCare Technologies during the first quarter valued at about $42,000. Finally, HFM Investment Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $60,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on GEHC shares. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their target price for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Wells Fargo & Company dropped their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research note on Wednesday, October 29th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $86.10.
GE HealthCare Technologies Trading Down 1.1%
NASDAQ:GEHC opened at $73.15 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The firm has a market cap of $33.32 billion, a PE ratio of 15.11, a price-to-earnings-growth ratio of 2.78 and a beta of 1.13. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The stock has a fifty day moving average price of $75.15 and a 200 day moving average price of $73.68.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were paid a $0.035 dividend. The ex-dividend date was Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
- Five stocks we like better than GE HealthCare Technologies
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 11/10 – 11/14
- How to Use the MarketBeat Dividend Calculator
- Are These 3 Oversold Tech Giants Ready to Rebound?
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- If You Wait for the Dip, Micron Technology Could Leave You Behind
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
